CareView System improves individual experience at Saline Memorial Hospital CareView Communications.

Sam Greco, CareView’s CEO, stated, ‘Our CareView Program is most effective for institutions like Saline that place a higher concern on quality care, basic safety, and patient satisfaction. ‘Physicians and patients have long believed that a failing heart can’t be repaired, but the CUPID trial with MYDICAR provides support to various other recent research suggesting that the deterioration of heart function can certainly be slowed down, leading to reduced hospitalizations and other cardiovascular events,’ stated Donna Mancini, M.D., medical director of cardiac transplantation at NewYork-Presbyterian Medical center/Columbia University INFIRMARY and professor of medication at Columbia University College of Physicians and Surgeons, who presented the study’s one-year outcomes during the American Heart Association Scientific Sessions 2010.Keating, Ph.D., a researcher in the Center for Applied Genomics at The Children’s Medical center of Philadelphia, and co-author of the scholarly study. Scientists knew that inflammation is associated with atherosclerosis already, the buildup of fatty deposits on artery walls that causes CHD, but as yet, no one had recognized an inflammatory agent leading to the disease. Likewise, it had been unknown whether a drug targeted at reducing inflammation might treat CHD. The current study centered on the interleukin-6 receptor , a signaling protein within the blood that raises inflammatory responses. This research provides robust proof that IL6R is usually implicated in coronary heart disease, said Keating. Furthermore, our analysis showed an existing anti-inflammatory medication, functioning on this receptor, may offer a new potential strategy for preventing CHD.

Other articles from category "medicine":

Random articles